The recalled vehicles may display a distorted, intermittent or blank image when the vehicle is in reverse, according to the ...
Two weeks after Amgen reported the top-line result of its CodeBreak-200 trial of Lumakras in lung cancer, the data has been presented in abstract form at ESMO, showing a 34% improvement in progression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback